Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma
Abstract
Authors
SL Klijn EB Torkilseng D Tyas A Sowdani B Malcolm A Mudd KM Johannesen
SL Klijn EB Torkilseng D Tyas A Sowdani B Malcolm A Mudd KM Johannesen
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now